3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
34
Ovarian Neoplasms
29
Peritoneal Neoplasms
27
Fallopian Tube Neoplasms
14
Colorectal Neoplasms
14
Carcinoma, Ovarian Epithelial
11
Appendiceal Neoplasms
7
Neoplasm Metastasis
4
Uterine Neoplasms
3
Recurrence
3
Pseudomyxoma Peritonei
3
Pancreatic Neoplasms
3
Carcinoma
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Peritoneal Diseases
2
Neoplasms
2
Mesothelioma, Malignant
2
Mesothelioma
2
Hyperthermic Intraperitoneal Chemotherapy
2
Gastrointestinal Neoplasms
2
Gastric Adenocarcinoma
2
Desmoplastic Small Round Cell Tumor
2
Colonic Neoplasms
2
Wilms Tumor
1
Stomach Diseases
1
Stage â…¢ Gastric Cancer
1
Stage IV Gastric Cancer With Metastasis
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Interventions
Radiotherapy
9
Doxorubicin
7
pazopanib
5
palbociclib
4
Trabectedin
4
Gemcitabine
4
ribociclib
3
pembrolizumab
3
eribulin
3
Magnetic Resonance Spectroscopy
3
selinexor
2
liposomal doxorubicin
2
avelumab
2
abemaciclib
2
Sunitinib
2
Radiation Dose Hypofractionation
2
Radiation
2
Immunoglobulin G
2
Ifosfamide
2
Docetaxel
2
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
2
zimberelimab
1
temsirolimus
1
sotigalimab
1
sodium thiosulfate
1
sitravatinib
1
silmitasertib
1
sargramostim
1
romidepsin
1
regorafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Liposarcoma
×
Hyperthermic Intraperitoneal Chemotherapy
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled